BAT in the Diagnosis of Drug Allergy: a Novel Tool in Clinical Daily Practice?
- 90 Downloads
Purpose of Review
The aim of this study is to critically review the relevant literature published on basophil activation test, presenting the current knowledge and future perspectives.
Basophil activation test (BAT) results varied accordingly to the class of the drug studied, and have promising results in immediate hypersensitivity reactions to pyrazolone (selective reactors), neuromuscular blockers, beta-lactams, and platinum compounds, all examples of classical IgE-mediated hypersensitivity drug reactions.
Currently, BAT is applied in research settings, but based in the results of our review, the test can be considered as a diagnostic tool for daily practice for selected patients and selected drugs, when the test is available, particularly for patients who experienced severe reactions and when diagnosis cannot be stablished by serum-specific IgE and skin testing, in order to avoid unnecessary drug provocations tests.
KeywordsBasophil activation test BAT Hypersensitivity reactions Drug allergy
Statement of Contribution
All authors meet the three conditions:
(1) Substantial contributions to conception of the study
(2) Drafting the article and revising it critically for important intellectual content
(3) Final approval of the version to be published
Compliance with Ethical Standards
Conflict of Interest
The authors declare no conflicts of interest relevant to this manuscript.
I confirm that this paper has been read and approved by all the co-authors, and that no conflicts of interest exist regarding its publication.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Hunziker T, Bruppacher R, Kuenzi UP, Maibach R, Braunschweig S, Halter F, et al. Classification of ADRs: a proposal for harmonization and differentiation based on the experience of the comprehensive hospital drug monitoring Bern/St. Gallen, 1974-1993. Pharmacoepidemiol Drug Saf. 2002;11(2):159–63.CrossRefGoogle Scholar
- 4.•• Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs -- an ENDA/EAACI drug allergy interest group position paper. Allergy. 2013;68(6):702–12. Most complete expert pannel regarding immediate skin test standardization. CrossRefGoogle Scholar
- 6.Torres MJ, Romano A, Blanca-Lopez N, Doña I, Canto G, Ariza A, et al. Immunoglobulin E-mediated hypersensitivity to amoxicillin: in vivo and in vitro comparative studies between an injectable therapeutic compound and a new commercial compound. Clin Exp Allergy. 2011;41(11):1595–601.CrossRefGoogle Scholar
- 7.Steiner M, Harrer A, Lang R, Schneider M, Ferreira T, Hawranek T, et al. Basophil activation test for investigation of IgE-mediated mechanisms in drug hypersensitivity. J Vis Exp. 2011;(55):1–7.Google Scholar
- 8.•• Giavina-Bianchi P, Galvao VR, Picard M, Caiado J, Castells MC. Basophil activation test is a relevant biomarker of the outcome of rapid desensitization in platinum compounds-allergy. J Allergy Clin Immunol Pract. 2017;5(3):728–36. Main case series studying BAT in platinum compound allergy. CrossRefGoogle Scholar
- 9.• Iwamoto T, Yuta A, Tabata T, Sugimoto H, Gabazza EC, Hirai H, et al. Evaluation of basophil CD203c as a predictor of carboplatin-related hypersensitivity reaction in patients with gynecologic cancer. Biol Pharm Bull. 2012;35(9):1487–95. Study showing a positive predective value of BAT in platinum compound allergy. CrossRefGoogle Scholar
- 15.•• Gómez E, Blanca-Lopez N, Torres MJ, Requena G, Rondon C, Canto G, et al. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy. 2009;39(8):1217–24. Large case series studying BAT in selective immediate reactions to dipyrone. CrossRefGoogle Scholar
- 18.Ebo DG, Faber M, Elst J, Van Gasse AL, Bridts CH, Mertens C, et al. In Vitro diagnosis of immediate drug hypersensitivity during anesthesia: a review of the literature. J Allergy Clin Immunol Pract. 2018;6(4):1176–84.Google Scholar
- 20.• Kowalski ML, Makowska JS, Blanca M, Bavbek S, Bochenek G, Bousquet J, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy. 2011;66(7):818–29. Enlightening consensus of hypersensitivity to nonsteroidal anti-inflammatory drugs. CrossRefGoogle Scholar
- 29.• Malbran A, Yeyati E, Rey GL, Galassi N. Diclofenac induces basophil degranulation without increasing CD63 expression in sensitive patients. Clin Exp Immunol. 2007;147(1):99–105. Study that provides insights on the mechanisms involved in diclofenac immediate hypersensitivity reactions. PubMedPubMedCentralGoogle Scholar
- 32.Abuaf N, Rostane H, Barbara J, Toly-Ndour C, Gaouar H, Mathelier-Fusade P, et al. Comparison of CD63 upregulation induced by NSAIDs on basophils and monocytes in patients with NSAID hypersensitivity. J Allergy (Cairo). 2012;2012:580873.Google Scholar
- 33.•• Gamboa P, Sanz ML, Caballero MR, Urrutia I, Antépara I, Esparza R, et al. The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin Exp Allergy. 2004;34(9):1448–57. Large case series studying BAT in immediate hypersensitivity reactions to NSAIDs. CrossRefGoogle Scholar
- 34.Sanz ML, Gamboa P, de Weck AL. A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol. 2005;136(1):58–72.CrossRefGoogle Scholar
- 35.•• De Weck AL, Sanz ML, Gamboa PM, Jermann JM, Kowalski M, Medrala W, et al. Nonsteroidal anti-inflammatory drug hypersensitivity syndrome: a multicenter study. II. Basophil activation by nonsteroidal anti-inflammatory drugs and its impact on pathogenesis. J Investig Allergol Clin Immunol. 2010;20(1):39–57. Large case series studying BAT in immediate hypersensitivity reactions to NSAIDs. PubMedGoogle Scholar
- 42.•• Leysen J, Uyttebroek A, Sabato V, Bridts CH, De Clerck LS, Ebo DG. Predictive value of allergy tests for neuromuscular blocking agents: tackling an unmet need. Clin Exp Allergy. 2014;44(8):1069–75. Large case series studying BAT in immediate hypersensitivity reactions to neuromuscular blocking agent. CrossRefGoogle Scholar
- 45.•• Kvedariene V, Kamey S, Ryckwaert Y, Rongier M, Bousquet J, Demoly P, et al. Diagnosis of neuromuscular blocking agent hypersensitivity reactions using cytofluorimetric analysis of basophils. Allergy. 2006;61(3):311–5. Large case series studying BAT in immediate hypersensitivity reactions to neuromuscular blocking agent. CrossRefGoogle Scholar
- 46.Dewachter P, Chollet-Martin S, Mouton-Faivre C, de Chaisemartin L, Nicaise-Roland P. Comparison of basophil activation test and skin testing performances in NMBA allergy. J Allergy Clin Immunol Pract. 2018;6(5):1681–89.Google Scholar
- 54.•• De Week AL, Sanz ML, Gamboa PM, Aberer W, Sturm G, Bilo MB, et al. Diagnosis of immediate-type beta-lactam allergy in vitro by flow-cytometric basophil activation test and sulfidoleukotriene production: a multicenter study. J Investig Allergol Clin Immunol. 2009;19(2):91–109. Large case series studying BAT in immediate hypersensitivity reactions to beta-lactams. PubMedGoogle Scholar
- 58.Thinnes A, Merk HF, Wurpts G, Röseler S, Lehmann S, Tenbrock K, et al. Individual risk assessment in the diagnosis of immediate type drug hypersensitivity reactions to betalactam and non-betalactam antibiotics using basophil activation test: a single center experience. Cutan Ocul Toxicol. 2018;37(4):309–18.Google Scholar
- 59.•• Salas M, Fernández-Santamaría R, Mayorga C, Barrionuevo E, Ariza A, Posadas T, et al. Use of the basophil activation test may reduce the need for drug provocation in amoxicillin-clavulanic allergy. J Allergy Clin Immunol Pract. 2018;6(3):1010–8.e2. Large case series studying BAT in amoxicillin-clavulanic allergy. CrossRefGoogle Scholar
- 67.Demir S, Gelincik A, Akdeniz N, Aktas-Cetin E, Olgac M, Unal D, et al. Usefulness of in vivo and in vitro diagnostic tests in the diagnosis of hypersensitivity reactions to quinolones and in the evaluation of cross-reactivity: a comprehensive study including the latest quinolone gemifloxacin. Allergy Asthma Immunol Res. 2017;9(4):347–59.CrossRefGoogle Scholar
- 72.de la Varga Martínez R, Gutiérrez Fernández D, Foncubierta Fernández A, Andrés García JA, Medina Varo F. Rapid subcutaneous desensitization for treatment of hypersensitivity reactions to etanercept in two patients with positive basophil activation test. Allergol Int. 2017;66(2):357–9.CrossRefGoogle Scholar
- 73.González-de-Olano D, Morgado JM, Juárez-Guerrero R, Sánchez-Muñoz L, Letellez-Fernández J, Malón-Giménez D, et al. Positive basophil activation test following anaphylaxis to pertuzumab and successful treatment with rapid desensitization. J Allergy Clin Immunol Pract. 2016;4(2):338–40.CrossRefGoogle Scholar
- 74.• Piva E, Chieco-Bianchi F, Krajcar V, Aversa S, Plebani M. Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: in vitro evaluation of rituximab hypersensitivity by basophil activation test. Am J Hematol. 2012;87(11):E130–1. Case series studying BAT in immediate hypersensitivity reactions to rituximab. CrossRefGoogle Scholar